Preparation of His-tagged armored RNA phage particles as a control for real-time reverse transcription-PCR detection of severe acute respiratory syndrome coronavirus

被引:23
|
作者
Cheng, Yangjian
Niu, Jianjun
Zhang, Yongyou
Huang, Jianwei
Li, Qingge
机构
[1] Xiamen Univ, Dept Biomed Sci, Key Lab Cell Biol & Tumor Cell Engn, Minist Educ,Mol Diagnost Lab, Xiamen 361005, Peoples R China
[2] Xiamen Univ, Sch Life Sci, Xiamen 361005, Peoples R China
[3] Xiamen Ctr Dis Control & Prevent, Xiamen 361005, Peoples R China
[4] Key Lab Chem Biol Fujian, Xiamen 361005, Peoples R China
关键词
D O I
10.1128/JCM.00713-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Armored RNA has been increasingly used as both an external and internal positive control in nucleic acid-based assays for RNA virus. In order to facilitate armored RNA purification, a His(6) tag was introduced into the loop region of the MS2 coat protein, which allows the exposure of multiple His tags on the surface during armored RNA assembly. The His-tagged armored RNA particles were purified to homogeneity and verified to be free of DNA contamination in a single run of affinity chromatography. A fragment of severe acute respiratory syndrome coronavirus (SARS-CoV) genome targeted for SARS-CoV detection was chosen for an external positive control preparation. A plant-specific gene sequence was chosen for a universal noncompetitive internal positive control preparation. Both controls were purified by Co2+ affinity chromatography and were included in a real-time reverse transcription-PCR assay for SARS-CoV. The noncompetitive internal positive control can be added to clinical samples before RNA extraction and enables the identification of potential inhibitive effects without interfering with target amplification. The external control could be used for the quantification of viral loads in clinical samples.
引用
收藏
页码:3557 / 3561
页数:5
相关论文
共 50 条
  • [1] Preparation of armored RNA as a control for multiplex real-time reverse transcription-PCR detection of influenza virus and severe acute respiratory syndrome coronavirus
    Yu, Xin-Fen
    Pan, Jing-Cao
    Ye, Rong
    Xiang, Hai-Qing
    Kou, Yu
    Huang, Zhi-Cheng
    JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (03) : 837 - 841
  • [2] Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus
    Bressler, AM
    Nolte, FS
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (03) : 987 - 991
  • [3] Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays
    Poon, LLM
    Chan, KH
    Wong, OK
    Cheung, TKW
    Ng, I
    Zheng, BJ
    Seto, WH
    Yuen, KY
    Guan, Y
    Peiris, JSM
    CLINICAL CHEMISTRY, 2004, 50 (01) : 67 - 72
  • [4] Development of two TaqMan real-time reverse transcription-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2
    Liu, Yiwei
    Wang, Yingying
    Wang, Xinming
    Xiao, Yan
    Chen, Lan
    Guo, Li
    Li, Jianguo
    Ren, Lili
    Wang, Jianwei
    BIOSAFETY AND HEALTH, 2020, 2 (04) : 232 - 237
  • [5] Development of two TaqMan real-time reverse transcription-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2
    Liu Yiwei
    Wang Yingying
    Wang Xinming
    Xiao Yan
    Chen Lan
    Guo Li
    Li Jianguo
    Ren Lili
    Wang Jianwei
    生物安全与健康(英文), 2020, 02 (04) : 232 - 237
  • [6] Real-Time Reverse Transcription-PCR Assay Panel for Middle East Respiratory Syndrome Coronavirus
    Lu, Xiaoyan
    Whitaker, Brett
    Sakthivel, Senthil Kumar K.
    Kamili, Shifaq
    Rose, Laura E.
    Lowe, Luis
    Mohareb, Emad
    Elassal, Emad M.
    Al-sanouri, Tarek
    Haddadin, Aktham
    Erdman, Dean D.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (01) : 67 - 75
  • [7] US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2
    Lu, Xiaoyan
    Wang, Lijuan
    Sakthivel, Senthilkumar K.
    Whitaker, Brett
    Murray, Janna
    Kamili, Shifaq
    Lynch, Brian
    Malapati, Lakshmi
    Burke, Stephen A.
    Harcourt, Jennifer
    Tamin, Azaibi
    Thornburg, Natalie J.
    Villanueva, Julie M.
    Lindstrom, Stephen
    EMERGING INFECTIOUS DISEASES, 2020, 26 (08) : 1654 - 1665
  • [8] Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-PCR assays for detection of severe acute respiratory syndrome coronavirus
    Mahony, JB
    Petrich, A
    Louie, L
    Song, XY
    Chong, S
    Smieja, M
    Chernesky, M
    Loeb, M
    Richardson, S
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (04) : 1471 - 1476
  • [9] Real-Time Quantitative Fluorescent Reverse Transcriptase-PCR for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus RNA
    Weijun Chen
    Zuyuan Xu
    Jingsong Mu
    Bo He
    Ling Yang
    Lin Lin
    Shufang Meng
    Feng Mu
    Haixue Gan
    Shengyong Huang
    Jie Wen
    Jianqiu Fang
    Jian Wang
    Molecular Diagnosis, 2004, 8 (4) : 231 - 235
  • [10] Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its first variants in fourplex real-time quantitative reverse transcription-PCR assays
    Durand, Mathieu
    Thibault, Philippe
    Levesque, Simon
    Brault, Ariane
    Carignan, Alex
    Valiquette, Louis
    Martin, Philippe
    Labbe, Simon
    MICROBIAL CELL, 2022, 9 (01): : 1 - 20